Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S-Scandinavian Starch for Severe Sepsis/Septic Shock trial): Study protocol, design and rationale for a double-blinded, randomised clinical trial

Anders Perner, Nicolai Haase, Jorn Wetterslev, Anders Aneman, Jyrki Tenhunen, Anne Berit Guttormsen, Gudmundur Klemenzson, Frank Pott, Karen Doris Bodker, Per Martin Badstolokken, Asger Bendtsen, Peter Soe-Jensen, Hamid Tousi, Morten Bestle, Malgorzata Pawlowicz, Robert Winding, Hans-Henrik Bulow, Claude Kancir, Morten Steensen, Jonas NielsenBjarne Fogh, Kristian R. Madsen, Nils H. Larsen, Marcela Carlsson, Jorgen Wiis, John Asger Petersen, Susanne Iversen, Ole Schoidt, Siv Leivdal, Pawel Berezowicz, Ville Pettilä, Esko Ruokonen, Pal Klepstad, Sari Karlsson, Maija Kaukonen, Juha Rutanen, Sigurbergur Karason, Anne Lene Kjaelgaard, Lars Brokso Holst, Jan Wernerman, Scandinavian Critical Care Trials

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number24
JournalTrials
Volume12
Pages (from-to)-
Number of pages9
ISSN1745-6215
DOIs
Publication statusPublished - 2011
MoE publication typeA1 Journal article-refereed

Fields of Science

  • ACUTE-RENAL-FAILURE
  • CRITICALLY-ILL PATIENTS
  • CONSENSUS CONFERENCE
  • ORGAN FAILURE
  • SEPTIC SHOCK
  • RISK-FACTOR
  • THERAPY
  • MULTICENTER
  • GUIDELINES
  • OUTCOMES
  • 3126 Surgery, anesthesiology, intensive care, radiology

Cite this